CABERGOLINE: DOSING FOR LACTATION SUPPRESSION

Cabergoline is a dopamine agonist primarily used in the treatment of conditions associated with hyperprolactinemia, such as prolactin-secreting pituitary tumors (prolactinomas). Its use extends to lactation suppression in certain clinical scenarios, particularly for women who choose not to breastfeed or wish to cease lactation after childbirth. Thi